Half of people with HIV can start treatment on same day
Switching to TAF-based PrEP improves kidney and bone markers – but does it raise cardiovascular risk?
Oral cabotegravir and rilpivirine still effective at 312 weeks
High levels of engagement in care by children and young people with HIV in the UK and Ireland
Rapid treatment start doesn't benefit all
Ibalizumab monoclonal antibody is effective in real-world use
Hepatitis C vaccine fails to prevent chronic infection
Do integrase inhibitors increase the risk of diabetes?
